BW Communities

Articles for Healthcare

Piramals To Invest More In US Custom Manufacturing Space

The latest $25 million investment is on the back of fast growing sterile (injections, ophthalmic solutions etc) market in the US

Read More
Pfizer Beats Estimates, But Branded Drugs Disappoint

Sales of generic medicines rose 16 percent to $6.04 billion, helped by Pfizer's $16 billion purchase last year of generic hospital products company Hospira

Read More
Lupin Buys 21 Generic Brands From Shionogi In Japanese Market

Under the terms of this agreement, Kyowa will book the sales of the 21 products after December 1, 2016, and Shionogi will receive 15.4 billion yen from Kyowa

Read More
Lupin To Buy 21 Branded Drugs From Japan's Shionogi

The portfolio will be transferred to Lupin on Dec. 31, subject to regulatory approvals and certain closing conditions, the companies said

Read More
NPPA Cuts Prices Of Cancer, HIV, Cardiac Drugs By Around 25%

The government fixes the prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment, having sales of more than 1 per cent

Read More
GlaxoSmithKline And Alphabet Create $715 Million Bioelectronics Firm

Verily Life Sciences - known as Google's life sciences unit until last year - and Britain's biggest drugmaker will together contribute 540 million pounds over seven years to Galvani Bioelectronics

Read More
Indoco Remedies Q1 Net Marginally Down At Rs 19.8 Crore

Indoco Remedies on Friday reported a marginal decline in net profit at Rs 19.8 crore for the June quarter against Rs 20.8 crore in the corresponding period last fiscal

Read More
Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug

The product is a generic version of Santarus Inc’s Zegerid powder for oral suspension, Ajanta Pharma says

Read More

Subscribe to our newsletter to get updates on our latest news